Detection of cytokines and nitric oxide synthase in skin lesions of Jorge Lobo's disease patients

References

• Brito AC, Quaresma JAS. Lacaziosis (Jorge Lobo's disease): review and update. An Bras Dermatol 2007; 82: 461–474 [in Portuguese].
   Google Scholar
• Almeida FP, Lacaz CS. Blastomycosis “Jorge Lobo like”. An Fac Med São Paulo 1949; 24: 5–37 [in Portuguese].
   Google Scholar
• Taborda PR, Taborda VA, McGinnis MR. Lacazia loboi gen. nov., comb. nov., the etiologic agent of lobomycosis. J Clin Microbiol 1999; 37: 2031–2033.
   PubMed Web of Science ®Google Scholar
• Vilela R, Rosa PS, Belone AF, . Molecular phylogeny of animal pathogen Lacazia loboi inferred from rDNA and DNA coding sequences. Mycol Res 2009; 113: 851–857.
   PubMedGoogle Scholar
• Lacaz CS, Baruzzi RG, Rosa MCB. Doença de Jorge Lobo, São Paulo: USP-IPSIS, 1986.
   Google Scholar
• Silva D. Lobo's mycosis. Rev Soc Bras Med Trop 1972; 6: 85–98 [in Portuguese].
   Google Scholar
• Opromolla DVA, Taborda PRO, Taborda VBA, . Lobomycosis: report of 40 new cases. An Bras Dermatol 1999; 74: 135–141 [in Portuguese].
   Google Scholar
• Opromolla DVA, Belone AFF, Taborda PRO, . Clinic-pathological correlation in 40 cases of lobomycosis. An Bras Dermatol 2000; 75: 425–434 [in Portuguese].
   Google Scholar
• Vilani-Moreno FR, Belone AFF, Soares CT, . Immunohistochemical characterization of the cellular infiltrate in Jorge Lobo's disease. Rev Iberoam Micol 2005; 22: 44–49.
   PubMedGoogle Scholar
• Vilani-Moreno FR, Lauris JRP, Opromolla DVA. Cytokine quantification in the supernatant of mononuclear cell cultures and in blood serum from patients with Jorge Lobo's disease. Mycopathologia 2004; 158: 17–24.
   PubMedGoogle Scholar
• Rodrigues LAP, Dalpino D, Dainezi EM, . Serum immunoglobulin measurement and protein electrophoresis profile in patients with Jorge Lobo's disease. 37° Congresso Brasileiro de Patologia Clínica, Rio de Janeiro, 2003: 157.
   Google Scholar
• Vilani-Moreno FR, Mozer E, Sene AMG, . In vitro and in situ activation of the complement system by the fungus Lacazia loboi. Rev Inst Med Trop São Paulo 2007; 49: 97–101.
   PubMedGoogle Scholar
• Mendonza L, Belone AFF, Vilela R, . Use of sera from humans and dolphins with lacaziosis and sera from experimentally infected mice for Western blot analyses of Lacazia loboi antigens. Clin Vaccine Immunol 2008; 15: 164–167.
   PubMedGoogle Scholar
• Hsu SM, Raine L, Fanger N. The use of anti-avidin antibody and avidin-biotin-peroxidase complex in immunoperoxidase techniques. Am J Clin Pathol 1981; 75: 816–821.
   PubMed Web of Science ®Google Scholar
• Vilani-Moreno F, Fecchio D, Mattos MC, . Study of pulmonary experimental paracoccidioidomycosis by analysis of bronchoalveolar lavage cells: resistant vs. susceptible mice. Mycopathologia 1998; 141: 79–91.
   PubMedGoogle Scholar
• Zar JH. Biostatistical Analysis, 3rd. New Jersey: Prentice Hall, 1996.
   Google Scholar
• Weiner HL. Oral tolerance: immune mechanisms and treatment of autoimmune diseases. Immunol Today 1997; 18: 335–343.
   PubMedGoogle Scholar
• D'Angeac AD, Dornand J, Emonds-Alt X, . Transforming growth factor type beta 1 (TGF-beta 1) down-regulates interleukin-2 production and up-regulates interleukin-2 receptor expression in a thymoma cell line. J Cell Physiol 1991; 147: 460–469.
   PubMedGoogle Scholar
• Tsunawaki S, Sporn M, Ding A, . Deactivation of macrophages by transforming growth factor-β. Nature 1988; 334: 260–262.
   PubMed Web of Science ®Google Scholar
• Ding A, Nathan CF, Graycar J, . Macrophage deactivation factor and transforming growth factors – β1–β2 and β3 inhibit induction of macrophage nitrogen oxide synthesis by IFN-γ. J Immunol 1990; 145: 940–944.
   PubMed Web of Science ®Google Scholar
• Geller P, Geller M. Cytokines and immunoregulation. An Acad Nac Med 1997; 157: 97–102 [in Portuguese].
   Google Scholar
• Goldsby RA, Kindt TJ, Osborne BA. Kuby Imunologia, 4th. Rio de Janeiro: Revinter, 2002.
   Google Scholar
• Xavier MB, Libonati RMF, Unger D, . Macrophage and TGF-β immunohistochemical expression in Jorge Lobo's disease. Hum Pathol 2008; 39: 269–274.
   PubMedGoogle Scholar
• Varella PPV, Forte WCN. Cytokines: review. Rev bras alergia imunopatol 2001; 24: 146–154 [in Portuguese].
   Google Scholar
• Vilani-Moreno FR, Opromolla DVA. Determination of the viability of Paracoccidioidesloboi in biopsies of patients with Jorge Lobo's disease. An Bras Dermatol 1997; 72: 433–437 [in Portuguese].
   Google Scholar
• Opromolla DVA, Vilani-Moreno FR, Belone AFF. Jorge Lobo's disease and Gomori's methenamine silver. An Bras Dermatol 1999; 74: 345–349 [in Portuguese].
   Google Scholar
• Stenger S, Mazzaccaro RJ, Uyemura K, . Differential effects of cytolytic T cell subsets on intracellular infection. Science 1997; 276: 1684–1687.
   PubMed Web of Science ®Google Scholar
• Ochoa MT, Stenger S, Sieling PA, . T-cell release of granulysin contributes to host defense in leprosy. Nat Med 2001; 7: 174–179.
   PubMedGoogle Scholar
• Levitz SM, Dupont MP, Smail EH. Direct activity of human T lymphocytes and natural killer cells against Cryptococcus neoformans. Infect Immun 1994; 62: 194–202.
   PubMed Web of Science ®Google Scholar
• Jimenez BE, Murphy JW. In vitro effects of natural killer cells against Paracoccidioides brasiliensis yeast phase. Infect Immun 1984; 46: 552–558.
   PubMed Web of Science ®Google Scholar
• Little D, Khanolkar-Young S, Coulthart A, . Immunohistochemical analysis of cellular infiltrate and gamma interferon, interleukin-12, and inducible nitric oxide synthase expression in leprosy type 1 (reversal) reactions before and during prednisolone treatment. Infect Immun 2001; 69: 3413–3417.
   PubMedGoogle Scholar
• Opromolla DVA, Belone AFF, Taborda PR, . Lymph node involvement in Jorge Lobo's disease: report of two cases. Int J Dermatol 2003; 42: 938–941.
   PubMedGoogle Scholar